Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Regulation of cell polarity and protrusion formation by targeting RhoA for degradation.

Science (New York, N.Y.) | Dec 5, 2003

The Rho family of small guanosine triphosphatases regulates actin cytoskeleton dynamics that underlie cellular functions such as cell shape changes, migration, and polarity. We found that Smurf1, a HECT domain E3 ubiquitin ligase, regulated cell polarity and protrusive activity and was required to maintain the transformed morphology and motility of a tumor cell. Atypical protein kinase C zeta (PKCzeta), an effector of the Cdc42/Rac1-PAR6 polarity complex, recruited Smurf1 to cellular protrusions, where it controlled the local level of RhoA. Smurf1 thus links the polarity complex to degradation of RhoA in lamellipodia and filopodia to prevent RhoA signaling during dynamic membrane movements.

Pubmed ID: 14657501 RIS Download

Mesh terms: Animals | Cell Line | Cell Line, Tumor | Cell Membrane | Cell Movement | Cell Polarity | Cell Size | Cell Transformation, Neoplastic | Cytoskeleton | Guanine Nucleotide Exchange Factors | Humans | Intercellular Junctions | Mice | NIH 3T3 Cells | Protein Kinase C | Protein Structure, Tertiary | Pseudopodia | RNA, Small Interfering | Signal Transduction | Transfection | Ubiquitin-Protein Ligases | cdc42 GTP-Binding Protein | rhoA GTP-Binding Protein

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NICHD NIH HHS, Id: R01 HD032429
  • Agency: NICHD NIH HHS, Id: R01 HD032429-06
  • Agency: NICHD NIH HHS, Id: R01 HD032429-07
  • Agency: NICHD NIH HHS, Id: HD32429

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.